Innovation in Bladder Cancer Immunotherapy.


Bladder cancer is understudied despite its high prevalence and its remarkable response to immunotherapy. Indeed, funding for studies to explore mechanisms of tumor immunity and novel new therapeutics is disproportionately lower for bladder cancer in comparison with malignancies of the breast, prostate, or lung. However, the recent successes of checkpoint… (More)
DOI: 10.1097/CJI.0000000000000130


Cite this paper

@article{Grossman2016InnovationIB, title={Innovation in Bladder Cancer Immunotherapy.}, author={H. Barton Grossman and Donald L. Lamm and Ashish Madhav Kamat and Stephen Keefe and John A. Taylor and Molly A Ingersoll}, journal={Journal of immunotherapy}, year={2016}, volume={39 8}, pages={291-7} }